Amdocs Reports Solid Q2 Results, Reiterates FY26 Outlook, Announces CFO Retirement & Successor
DOX is trading near its 52-week low of $59.4 (4.3% above the low).
Summary
Amdocs announced Q2 FY2026 results surpassing guidance, maintained its full-year outlook with tightened ranges, and disclosed a CFO transition, while also boosting liquidity and continuing share repurchases.
Key Events · Earnings and Guidance · DOX
-
Q2 FY2026 Financial Performance
Reported revenue of $1.172 billion (up 3.9% YoY) and non-GAAP diluted EPS of $1.78, both exceeding the midpoint of the company's guidance range.
-
Full-Year FY2026 Outlook Reiterated
Tightened the full-year FY2026 revenue growth outlook to 2.0%-4.0% (constant currency) and non-GAAP diluted EPS growth to 5.0%-7.0%, while reiterating the midpoints of both ranges.
-
CFO Retirement and Succession
Tamar Rapaport-Dagim, CFO and COO, announced her retirement, with Tal Rozenfeld, General Manager Head of Finance, appointed as the new CFO effective June 1, 2026.
-
Enhanced Financial Flexibility
Established an $800 million commercial paper program and increased its revolving credit facility from $500 million to $800 million, enhancing short-term funding and liquidity.
Analysis · DOX · Technology
Amdocs reported Q2 FY2026 financial results that exceeded the midpoint of its guidance for both revenue and non-GAAP diluted EPS. The company also tightened its full-year FY2026 revenue and non-GAAP EPS growth outlook ranges while reiterating the midpoints, signaling confidence in its performance despite monitoring macroeconomic conditions. Additionally, the long-serving CFO announced retirement, with an internal successor appointed, ensuring a managed transition. The company also enhanced its financial flexibility by establishing an $800 million commercial paper program and increasing its revolving credit facility, alongside a significant share repurchase program.
At the time of this filing, DOX was trading at $61.93 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.4B. The 52-week trading range was $59.40 to $95.41. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.